DSM Venturing

Type

Venture Capital

Status

Active

Location

Cambridge, United States

Total investments

91

Average round size

7M

Portfolio companies

64

Rounds per year

3.96

Lead investments

30

Follow on index

0.29

Exits

9

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyFood and BeverageFood ProcessingFitnessHealth CareWellnessManufacturingMedical DeviceMedical3D Printing

Summary

DSM Venturing is the famous VC, which was founded in 1902. The leading representative office of defined VC is situated in the Urmond. The company was established in Europe in The Netherlands.

The usual things for fund are deals in the range of 5 - 10 millions dollars. This DSM Venturing works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Segetis, Verdezyne, Raycatch Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical, Health Care.

Besides them, we counted 2 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the DSM Venturing, startups are often financed by BASF Venture Capital, Burrill & Company, Prelude Trust. The meaningful sponsors for the fund in investment in the same round are BASF Venture Capital, Burrill & Company, Prelude Trust. In the next rounds fund is usually obtained by Burrill & Company, BASF Venture Capital, Prelude Trust.

Show more

Investor highlights

Industry focus
HealthcareFoodtechBiotech/Life SciencesConsumer/Retail
Stage focus
GeneralistSeed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 39 more
Check size
109K — 22M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
91
Lead investments
30
Exits
9
Rounds per year
3.96
Follow on index
0.29
Investments by industry
  • Health Care (37)
  • Biotechnology (35)
  • Manufacturing (21)
  • Food and Beverage (14)
  • Wellness (13)
  • Show 62 more
Investments by region
  • United States (51)
  • Netherlands (9)
  • United Kingdom (8)
  • Israel (4)
  • Canada (7)
  • Show 6 more
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
920K
Group Appearance index
0.77
Avg. company exit year
11

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Miach Orthopaedics 25 Jan 2023 Biotechnology, Health Care, Wellness, Manufacturing, Medical Device, Medical Early Stage Venture 30M United States, Massachusetts, Boston
NutriLeads 18 Dec 2023 Food and Beverage, Food Processing, Health Care, Organic Food Late Stage Venture 5M Gelderland, The Netherlands, Netherlands

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.